Novavax announced on July 7, 2020 that it has been awarded $1.6 billion from the United States federal government to participate in Operation Warp Speed, a program that intends to deliver a safe, effective vaccine for COVID-19 in 2021.
The agreement will fund the late-stage clinical develo